UBS AM’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $554K | Sell |
|
|||||
|
2024
Q4 | $1.37M | Buy |
|
|||||
|
2024
Q3 | $1.71M | Sell |
|
|||||
|
2024
Q2 | $1.68M | Buy |
|
|||||
|
2024
Q1 | $1.71M | Hold |
|
|||||
|
2023
Q4 | $1.29M | Sell |
|
|||||
|
2023
Q3 | $6.3M | Sell |
|
|||||
|
2023
Q2 | $19.4M | Hold |
|
|||||
|
2023
Q1 | $19.4M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $55M | Sell |
|
|||||
|
2022
Q2 | $70.1M | Sell |
|
|||||
|
2022
Q1 | $96.5M | Sell |
|
|||||
|
2021
Q4 | $189M | Buy |
|
|||||
|
2021
Q3 | $203M | Buy |
|
|||||
|
2021
Q2 | $148M | Buy |
|
|||||
|
2021
Q1 | $117M | Sell |
|
|||||
|
2020
Q4 | $106M | Buy |
|